HER2/neu expression in cancer: The pathologist as diagnostician or prophet?

Human Pathology

Volumn 34, Issue 7, 2003, Pages 635-638

  Foster, Christopher S ^a,b   Gosden, Christine M ^a   Ke, Youqiang ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b European Editorial Office   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GENE PRODUCT; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; TYROSINE KINASE RECEPTOR;

CANCER DIAGNOSIS; CHROMOSOMAL LOCALIZATION; EDITORIAL; GENE SEQUENCE; HISTOPATHOLOGY; MOLECULAR CLONING; ONCOGENE NEU; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 0037707280     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(03)00357-5     Document Type: Editorial

References (16)

1. Nuciforo PG, Pellegrini C, Fasani R, et al: Molecular and immunohistological analysis of HER2/neu oncogene in synovial sarcoma. HUM PATHOL 34:639-645, 2003
2. Schechter AL, Stem DF, Vaidyanathan L, et al: The neu oncogene: An erbB related gene encoding a 185,000-Mr tumour antigen. Nature 312:513-516, 1984
3. Bargmann CI, Hung MC, Weinberg RA: The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 319:226-230, 1986
4. Ali IU, Campbell G, Lidereau R, et al: Lack of evidence for the prognostic significance of c-erbB-2 amplification in human breast carcinoma. Oncogene Res 3:130-146, 1988
5. Berger MS, Locher GW, Saurer S, et al: Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 48:1238-1243, 1988
6. Scholl S, Buezeboc P, Pouillart P: Targeting HER2 in other tumor types. Ann Oncol 12:S81-S87, 2001
7. Slamon DJ, Clark GM, Wong SG, et al: Human breast cancer: Correlation to relapse and survival with amplification of the HER2/ neu oncogene. Science 235:177-182, 1987
8. Wright C, Angus B, Nicholson S, et al: Expression of c-erbB-2 oncoprotein: A prognostic indicator in human breast cancer. Cancer Res 49:2087-2090, 1989
9. Slamon DJ, Leyland-Jones B, Shak S, et al: Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpress HER2. N Engl J Med 344:783-792, 2001
10. Peethambaram PP, Cliby WA, Lubiniecki G, et al: HER2/neu expression in ovarian cancer: Pre- and postexposure to platinum chemotherapy. Gynecol Oncol 89:99-104, 2003
11. Foster H, Knox S, Ganti AK, et al: HER2/neu overexpression detected by immunohistochemistry in soft tissue sarcomas. Am J Clin Oncol 26:188-191, 2003
12. Nathanson DR, Culliford AT, Shia J, et al: HER2/neu expression and gene amplification in colon cancer. Int J Cancer 105: 796-802, 2003
13. Ramsauer VP, Carothers Carraway CA, Salas PJ, et al: Muc4/Sialomucin complex, the intramembrane ErbB2 ligand, translocates ErbB2 to the apical surface in polarized epithelial cells. J Biochem (in press)
14. Foster CS, Finegold MJ, Wolman SR: Rallying call or death knell? HUM PATHOL 25:553-554, 1994
15. Nash JRG, West KP, Foster CS: The teaching of anatomic pathology in England and Wales: A transatlantic view. HUM PATHOL 32:1154-1156, 2001
16. Weinstein RS: The Education of Professionals. HUM PATHOL 34:415-416, 2003